BridgeMD
New treatment option for Wrist Osteoarthritis
Official title PRC With Meniscal Allograft Arthroplasty for Wrist Osteoarthritis
ClinicalTrials.gov ID: NCT05412615
What this study is testing
- What it's testing
- This study plans to learn more about the effect of adding tissue graft for wrist osteoarthritis reconstruction procedures. Previous studies have shown better allograft stability, and no documented foreign body reaction than with silicone and other synthetic materials.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 80
You may be able to join if
- symptomatic wrist arthritis associated with SLAC or SNAC pathology
- Patients 30 years or older or 80 years or younger
You likely can't join if
- Patients younger than 29 years or older than 80 years
- History of previous surgery related to wrist osteoarthritis
The study team makes the final eligibility decision.
Where it's taking place
- Englewood, Colorado, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Englewood, Colorado, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.